WO1994001095A3 - Medicaments pour le traitement de douleurs viscerales et de migraines - Google Patents
Medicaments pour le traitement de douleurs viscerales et de migraines Download PDFInfo
- Publication number
- WO1994001095A3 WO1994001095A3 PCT/GB1993/001377 GB9301377W WO9401095A3 WO 1994001095 A3 WO1994001095 A3 WO 1994001095A3 GB 9301377 W GB9301377 W GB 9301377W WO 9401095 A3 WO9401095 A3 WO 9401095A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- migraine
- treatment
- visceral pain
- medicaments
- dose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002139440A CA2139440A1 (fr) | 1992-07-03 | 1993-06-30 | Medicaments pour le traitement des douleurs viscerales et de la migraine |
EP93914854A EP0650355A1 (fr) | 1992-07-03 | 1993-06-30 | Medicaments pour le traitement de douleurs viscerales et de migraines |
AU45076/93A AU4507693A (en) | 1992-07-03 | 1993-06-30 | Medicaments for the treatment of visceral pain and migraine |
JP6503078A JPH07508530A (ja) | 1992-07-03 | 1993-06-30 | 内臓の痛みおよび偏頭痛の治療薬 |
KR1019940704887A KR950702112A (ko) | 1992-07-03 | 1994-12-31 | 내장 진통 및 편두통의 치료 약물(Medicaments for the treatment of visceral pain and migraine) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929214184A GB9214184D0 (en) | 1992-07-03 | 1992-07-03 | Pharmaceuticals |
GB9214184.5 | 1992-07-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994001095A2 WO1994001095A2 (fr) | 1994-01-20 |
WO1994001095A3 true WO1994001095A3 (fr) | 1994-04-14 |
Family
ID=10718169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1993/001377 WO1994001095A2 (fr) | 1992-07-03 | 1993-06-30 | Medicaments pour le traitement de douleurs viscerales et de migraines |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0650355A1 (fr) |
JP (1) | JPH07508530A (fr) |
KR (1) | KR950702112A (fr) |
AU (1) | AU4507693A (fr) |
CA (1) | CA2139440A1 (fr) |
GB (1) | GB9214184D0 (fr) |
WO (1) | WO1994001095A2 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5852014A (en) * | 1992-03-12 | 1998-12-22 | Smithkline Beecham P.L.C. | Condensed indole derivatives as 5HT4 -receptor antagonists |
US5998409A (en) * | 1992-03-12 | 1999-12-07 | Smithkline Beecham Plc | Condensed indole derivatives as 5HT4 -receptor antagonists |
US5726187A (en) * | 1992-10-16 | 1998-03-10 | Smithkline Beecham Plc | N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists |
GB9721139D0 (en) | 1997-10-07 | 1997-12-03 | Glaxo Group Ltd | Medicaments |
DE19807535A1 (de) * | 1998-02-21 | 1999-08-26 | Asta Medica Ag | Pharmazeutische Kombinationen mit Tramadol |
ES2327600T3 (es) * | 1999-02-18 | 2009-11-02 | Novasearch Ag | Uso de antagonistas del receptor de la 5-ht3 para el tratamiento de enfermedades musculoesqueleticas. |
TWI263496B (en) * | 1999-12-10 | 2006-10-11 | Novartis Ag | Pharmaceutical combinations and their use in treating gastrointestinal disorders |
GB0216027D0 (en) | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
EP1567163B1 (fr) | 2003-01-13 | 2007-04-11 | Dynogen Pharmaceuticals Inc. | Methode pour traiter des nausees, des vomissements, des haut-le-coeur ou une association de ces symptomes |
GB0302662D0 (en) * | 2003-02-05 | 2003-03-12 | Strakan Ltd | Transdermal granisetron |
US20060263421A1 (en) | 2005-05-18 | 2006-11-23 | Abeille Pharmaceuticals Inc | Transdermal Method and Patch for Nausea |
Citations (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0189002A2 (fr) * | 1984-12-20 | 1986-07-30 | Sandoz Ag | Traitement de maladies gastro-intestinales utilisant des 5-HT3 antagonistes |
EP0254584A2 (fr) * | 1986-07-25 | 1988-01-27 | Beecham Group Plc | Composés azabicycliques, procédé pour leur préparation et leur utilisation pharmaceutique |
GB2192885A (en) * | 1986-07-23 | 1988-01-27 | Glaxo Group Ltd | Heterocyclic compounds |
EP0266899A2 (fr) * | 1986-10-03 | 1988-05-11 | Glaxo Group Limited | Dérivés d'indole |
EP0272876A2 (fr) * | 1986-12-17 | 1988-06-29 | Glaxo Group Limited | Application des dérivés hétérocycliques pour la fabrication de médicaments |
EP0279512A2 (fr) * | 1987-01-19 | 1988-08-24 | Beecham Group Plc | Emploi de certains antagonistes du récépteur 5-HT3 pour le traitement des douleurs viscérales |
EP0287196A1 (fr) * | 1987-02-18 | 1988-10-19 | Beecham Group Plc | Dérivés de l'indole, un procédé pour leur préparation et compositions pharmaceutiques les contenant |
EP0289170A2 (fr) * | 1987-04-25 | 1988-11-02 | Beecham Group Plc | Composés azabicycliques, leur procédé de préparation et compositions pharmaceutiques les contenant |
EP0315316A2 (fr) * | 1987-10-02 | 1989-05-10 | Beecham Group Plc | Dérivés d'imidazole, procédé pour leur préparation, compositions pharmaceutiques les contenant, et leur application pharmaceutique |
EP0315390A2 (fr) * | 1987-11-04 | 1989-05-10 | Beecham Group Plc | Composés nouveaux de 4-oxobenzotriazine et 4-oxoquinazoline |
EP0317088A1 (fr) * | 1987-10-22 | 1989-05-24 | Glaxo Group Limited | Dérivés cétoniques |
WO1989009217A1 (fr) * | 1988-03-23 | 1989-10-05 | Beecham Group Plc | Nouveaux composes |
EP0336759A1 (fr) * | 1988-04-07 | 1989-10-11 | Glaxo Group Limited | Dérivés d'imidazole |
EP0345956A1 (fr) * | 1988-05-20 | 1989-12-13 | Glaxo Group Limited | Cétones tricycliques |
EP0347229A1 (fr) * | 1988-06-16 | 1989-12-20 | Glaxo Group Limited | Dérivés de l'indole |
EP0351385A2 (fr) * | 1988-07-12 | 1990-01-17 | BOEHRINGER INGELHEIM ITALIA S.p.A. | Dérivés d'amidino et de guanidino |
EP0356098A2 (fr) * | 1988-08-15 | 1990-02-28 | Glaxo Group Limited | Dérivés de lactames |
EP0357416A2 (fr) * | 1988-09-01 | 1990-03-07 | Glaxo Group Limited | Utilisation des antagonistes de la sérotonine dans le traitement de l'asservissement aux drogues |
EP0358903A2 (fr) * | 1988-07-29 | 1990-03-21 | Dainippon Pharmaceutical Co., Ltd. | Dérivés d'acide indazole-3-carboxylique |
EP0361317A2 (fr) * | 1988-09-27 | 1990-04-04 | Fujisawa Pharmaceutical Co., Ltd. | Dérivés de pyridoindole et leur procédé de préparation |
EP0364274A1 (fr) * | 1988-10-13 | 1990-04-18 | Glaxo Group Limited | Dérivés d'imidazole |
EP0376624A1 (fr) * | 1988-12-22 | 1990-07-04 | Yamanouchi Pharmaceutical Co. Ltd. | Dérivés de 4,5,6,7-tétrahydrobenzimidazole et leur préparation |
EP0377967A2 (fr) * | 1988-12-13 | 1990-07-18 | Beecham Group Plc | Dérivés du 9-aza-3-(oxa/thia)-bicyclo[3,2,1]nonane, procédé et intermédiaires pour leur préparation et compositions pharmaceutiques les contenant |
EP0381422A1 (fr) * | 1989-02-02 | 1990-08-08 | Yamanouchi Pharmaceutical Co. Ltd. | Dérivés de tétrahydrobenzimidazole |
EP0385722A2 (fr) * | 1989-02-28 | 1990-09-05 | Glaxo Group Limited | Dérivés de tricyclique lactame et les compositions pharmaceutiques qui les contiennent |
EP0387431A1 (fr) * | 1989-03-14 | 1990-09-19 | Beecham Group Plc | Dérivés d'imidazole, procédés de leur préparation et leur application comme produits pharmaceutiques |
WO1991001316A1 (fr) * | 1989-07-21 | 1991-02-07 | Beecham Group Plc | Nouveau derive de 9-azabicyclo[3.3.1] nonane |
EP0417746A2 (fr) * | 1989-09-11 | 1991-03-20 | G.D. Searle & Co. | Amides d'acides aromatiques N-substituées par azabicyclo[3.3.0]octane |
EP0419397A1 (fr) * | 1989-09-08 | 1991-03-27 | Novo Nordisk A/S | Dérivés de l'urée, leur préparation et leur utilisation |
WO1991007402A1 (fr) * | 1989-11-17 | 1991-05-30 | Pfizer Inc. | Amides et esters azabicyliques antagonistes du recepteur de 5-ht¿3? |
WO1991012254A1 (fr) * | 1990-02-16 | 1991-08-22 | Novo Nordisk A/S | Composes d'uree substitues, preparation et utilisation des ces composes |
EP0450757A2 (fr) * | 1990-02-22 | 1991-10-09 | Glaxo Group Limited | Utilisation des antagonistes du 5-hydroxytryptamine pour le traitement des maladies mentales dès l'origine de l'enfance |
EP0451538A2 (fr) * | 1990-03-19 | 1991-10-16 | Fujisawa Pharmaceutical Co., Ltd. | Utilisation des dérivés du pyridoindole dans le traitement des troubles ischémiques |
EP0454121A2 (fr) * | 1990-04-27 | 1991-10-30 | G.D. Searle & Co. | Composés azatétracycliques |
WO1992005174A1 (fr) * | 1990-09-26 | 1992-04-02 | Beecham Group Plc | Derives de 3,9-diazabicyclo (3.3.1) nonan-7-yl, procede et intermediaires de preparation et compositions pharmaceutiques les contenant |
US5126343A (en) * | 1989-09-11 | 1992-06-30 | G. D. Searle & Co. | N-azabicyclo [3.3.0]octane amides of aromatic acids |
WO1992011259A1 (fr) * | 1990-12-19 | 1992-07-09 | Beecham Group Plc | Amides azabicycliques ou esters d'acides benzoïques halogenes |
WO1992012149A1 (fr) * | 1991-01-09 | 1992-07-23 | Smithkline Beecham Plc | Derives azabicydiques et azatricydiques, leurs procedes et intermediaires de preparation et compositions pharmaceutiques les contenant |
US5137893A (en) * | 1991-03-07 | 1992-08-11 | G. D. Searle & Co. | Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof |
WO1992014733A1 (fr) * | 1991-02-23 | 1992-09-03 | Smithkline Beecham P.L.C. | Produits pharmaceutiques |
EP0504679A1 (fr) * | 1991-03-07 | 1992-09-23 | G.D. Searle & Co. | Imidazopyridines comme antagonistes 5-HT3 sérotonergiques |
EP0518767A2 (fr) * | 1991-06-11 | 1992-12-16 | Merrell Pharmaceuticals Inc. | Dérivés d'analogues d'amide de quinolizines à pont méthano |
EP0554794A1 (fr) * | 1992-02-04 | 1993-08-11 | Eisai Co., Ltd. | Dérivés d'acides aminobenzoiques |
-
1992
- 1992-07-03 GB GB929214184A patent/GB9214184D0/en active Pending
-
1993
- 1993-06-30 WO PCT/GB1993/001377 patent/WO1994001095A2/fr not_active Application Discontinuation
- 1993-06-30 AU AU45076/93A patent/AU4507693A/en not_active Abandoned
- 1993-06-30 JP JP6503078A patent/JPH07508530A/ja active Pending
- 1993-06-30 CA CA002139440A patent/CA2139440A1/fr not_active Abandoned
- 1993-06-30 EP EP93914854A patent/EP0650355A1/fr not_active Withdrawn
-
1994
- 1994-12-31 KR KR1019940704887A patent/KR950702112A/ko not_active Application Discontinuation
Patent Citations (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0189002A2 (fr) * | 1984-12-20 | 1986-07-30 | Sandoz Ag | Traitement de maladies gastro-intestinales utilisant des 5-HT3 antagonistes |
GB2192885A (en) * | 1986-07-23 | 1988-01-27 | Glaxo Group Ltd | Heterocyclic compounds |
EP0254584A2 (fr) * | 1986-07-25 | 1988-01-27 | Beecham Group Plc | Composés azabicycliques, procédé pour leur préparation et leur utilisation pharmaceutique |
EP0266899A2 (fr) * | 1986-10-03 | 1988-05-11 | Glaxo Group Limited | Dérivés d'indole |
EP0272876A2 (fr) * | 1986-12-17 | 1988-06-29 | Glaxo Group Limited | Application des dérivés hétérocycliques pour la fabrication de médicaments |
EP0279512A2 (fr) * | 1987-01-19 | 1988-08-24 | Beecham Group Plc | Emploi de certains antagonistes du récépteur 5-HT3 pour le traitement des douleurs viscérales |
EP0287196A1 (fr) * | 1987-02-18 | 1988-10-19 | Beecham Group Plc | Dérivés de l'indole, un procédé pour leur préparation et compositions pharmaceutiques les contenant |
EP0289170A2 (fr) * | 1987-04-25 | 1988-11-02 | Beecham Group Plc | Composés azabicycliques, leur procédé de préparation et compositions pharmaceutiques les contenant |
EP0315316A2 (fr) * | 1987-10-02 | 1989-05-10 | Beecham Group Plc | Dérivés d'imidazole, procédé pour leur préparation, compositions pharmaceutiques les contenant, et leur application pharmaceutique |
EP0317088A1 (fr) * | 1987-10-22 | 1989-05-24 | Glaxo Group Limited | Dérivés cétoniques |
EP0315390A2 (fr) * | 1987-11-04 | 1989-05-10 | Beecham Group Plc | Composés nouveaux de 4-oxobenzotriazine et 4-oxoquinazoline |
WO1989009217A1 (fr) * | 1988-03-23 | 1989-10-05 | Beecham Group Plc | Nouveaux composes |
EP0336759A1 (fr) * | 1988-04-07 | 1989-10-11 | Glaxo Group Limited | Dérivés d'imidazole |
EP0345956A1 (fr) * | 1988-05-20 | 1989-12-13 | Glaxo Group Limited | Cétones tricycliques |
EP0347229A1 (fr) * | 1988-06-16 | 1989-12-20 | Glaxo Group Limited | Dérivés de l'indole |
EP0351385A2 (fr) * | 1988-07-12 | 1990-01-17 | BOEHRINGER INGELHEIM ITALIA S.p.A. | Dérivés d'amidino et de guanidino |
EP0358903A2 (fr) * | 1988-07-29 | 1990-03-21 | Dainippon Pharmaceutical Co., Ltd. | Dérivés d'acide indazole-3-carboxylique |
EP0356098A2 (fr) * | 1988-08-15 | 1990-02-28 | Glaxo Group Limited | Dérivés de lactames |
EP0357416A2 (fr) * | 1988-09-01 | 1990-03-07 | Glaxo Group Limited | Utilisation des antagonistes de la sérotonine dans le traitement de l'asservissement aux drogues |
EP0361317A2 (fr) * | 1988-09-27 | 1990-04-04 | Fujisawa Pharmaceutical Co., Ltd. | Dérivés de pyridoindole et leur procédé de préparation |
EP0364274A1 (fr) * | 1988-10-13 | 1990-04-18 | Glaxo Group Limited | Dérivés d'imidazole |
EP0377967A2 (fr) * | 1988-12-13 | 1990-07-18 | Beecham Group Plc | Dérivés du 9-aza-3-(oxa/thia)-bicyclo[3,2,1]nonane, procédé et intermédiaires pour leur préparation et compositions pharmaceutiques les contenant |
EP0376624A1 (fr) * | 1988-12-22 | 1990-07-04 | Yamanouchi Pharmaceutical Co. Ltd. | Dérivés de 4,5,6,7-tétrahydrobenzimidazole et leur préparation |
EP0381422A1 (fr) * | 1989-02-02 | 1990-08-08 | Yamanouchi Pharmaceutical Co. Ltd. | Dérivés de tétrahydrobenzimidazole |
EP0385722A2 (fr) * | 1989-02-28 | 1990-09-05 | Glaxo Group Limited | Dérivés de tricyclique lactame et les compositions pharmaceutiques qui les contiennent |
EP0387431A1 (fr) * | 1989-03-14 | 1990-09-19 | Beecham Group Plc | Dérivés d'imidazole, procédés de leur préparation et leur application comme produits pharmaceutiques |
WO1991001316A1 (fr) * | 1989-07-21 | 1991-02-07 | Beecham Group Plc | Nouveau derive de 9-azabicyclo[3.3.1] nonane |
EP0419397A1 (fr) * | 1989-09-08 | 1991-03-27 | Novo Nordisk A/S | Dérivés de l'urée, leur préparation et leur utilisation |
US5126343A (en) * | 1989-09-11 | 1992-06-30 | G. D. Searle & Co. | N-azabicyclo [3.3.0]octane amides of aromatic acids |
EP0417746A2 (fr) * | 1989-09-11 | 1991-03-20 | G.D. Searle & Co. | Amides d'acides aromatiques N-substituées par azabicyclo[3.3.0]octane |
WO1991007402A1 (fr) * | 1989-11-17 | 1991-05-30 | Pfizer Inc. | Amides et esters azabicyliques antagonistes du recepteur de 5-ht¿3? |
WO1991012254A1 (fr) * | 1990-02-16 | 1991-08-22 | Novo Nordisk A/S | Composes d'uree substitues, preparation et utilisation des ces composes |
EP0450757A2 (fr) * | 1990-02-22 | 1991-10-09 | Glaxo Group Limited | Utilisation des antagonistes du 5-hydroxytryptamine pour le traitement des maladies mentales dès l'origine de l'enfance |
EP0451538A2 (fr) * | 1990-03-19 | 1991-10-16 | Fujisawa Pharmaceutical Co., Ltd. | Utilisation des dérivés du pyridoindole dans le traitement des troubles ischémiques |
EP0454121A2 (fr) * | 1990-04-27 | 1991-10-30 | G.D. Searle & Co. | Composés azatétracycliques |
WO1992005174A1 (fr) * | 1990-09-26 | 1992-04-02 | Beecham Group Plc | Derives de 3,9-diazabicyclo (3.3.1) nonan-7-yl, procede et intermediaires de preparation et compositions pharmaceutiques les contenant |
WO1992011259A1 (fr) * | 1990-12-19 | 1992-07-09 | Beecham Group Plc | Amides azabicycliques ou esters d'acides benzoïques halogenes |
WO1992012149A1 (fr) * | 1991-01-09 | 1992-07-23 | Smithkline Beecham Plc | Derives azabicydiques et azatricydiques, leurs procedes et intermediaires de preparation et compositions pharmaceutiques les contenant |
WO1992014733A1 (fr) * | 1991-02-23 | 1992-09-03 | Smithkline Beecham P.L.C. | Produits pharmaceutiques |
US5137893A (en) * | 1991-03-07 | 1992-08-11 | G. D. Searle & Co. | Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof |
EP0504679A1 (fr) * | 1991-03-07 | 1992-09-23 | G.D. Searle & Co. | Imidazopyridines comme antagonistes 5-HT3 sérotonergiques |
EP0518767A2 (fr) * | 1991-06-11 | 1992-12-16 | Merrell Pharmaceuticals Inc. | Dérivés d'analogues d'amide de quinolizines à pont méthano |
EP0554794A1 (fr) * | 1992-02-04 | 1993-08-11 | Eisai Co., Ltd. | Dérivés d'acides aminobenzoiques |
Non-Patent Citations (3)
Title |
---|
A. PRIOR ET AL.: "REDUCTION OF RECTAL SENSITIVITY AND POST-PRANDIAL MOTILITY BY GRANISETRON, A 5-HT3 RECEPTOR ANTAGONIST, IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (IBS)", GUT, vol. 31, no. 10, 1990, pages A1174 * |
N.J.TALLEY: "REVIEW ARTICLE: 5-HYDROXYTRYPTAMINE AGONISTA AND ANTAGONISTS IN THE MODULATION OF GASTROINTESTINAL MOTILITY AND SENSATION: CLIMICAL IMPLICATIONS", ALIMENT.PHARMACOL.THER., vol. 6, no. 3, June 1992 (1992-06-01), pages 273 - 289 * |
R.BERKOW, ED.: "THE MERCK MANUAL OF DIAGNOSIS AND THERAPY, 15TH EDITION", MERCK & CO., RAHWAY, N.J. * |
Also Published As
Publication number | Publication date |
---|---|
GB9214184D0 (en) | 1992-08-12 |
EP0650355A1 (fr) | 1995-05-03 |
KR950702112A (ko) | 1995-06-19 |
AU4507693A (en) | 1994-01-31 |
JPH07508530A (ja) | 1995-09-21 |
WO1994001095A2 (fr) | 1994-01-20 |
CA2139440A1 (fr) | 1994-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9603298A3 (en) | Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation, and their use for the preparation of pharmaceutical compositions | |
WO1999017755A3 (fr) | Medicaments | |
WO1994001095A3 (fr) | Medicaments pour le traitement de douleurs viscerales et de migraines | |
WO2000064441A3 (fr) | Medicament | |
UA27776C2 (uk) | Похідні хінуклідину та їх фармацевтично прийнятні солі, що є антагоністами речовини р у ссавців, фармацевтична композиція, що має антагоністичну дію на речовину р у ссавців | |
MY116002A (en) | Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis | |
WO1995031985A3 (fr) | Compositions pharmaceutiques contenant un antagoniste des opiaces et des sels de calcium, et leur utilisation dans le traitement de pathologies a mediation endorphinique | |
ES2096312T3 (es) | Derivado de quinuclidina como antagonista de la sustancia p. | |
IE872051L (en) | Use of serotonin antagonists | |
IL102917A0 (en) | Pharmaceutical composition comprising a calcium agonist or antagonist | |
UA41311C2 (uk) | КОНДЕНСОВАНІ ІНДОЛЬНІ ПОХІДНІ ЯК АНТАГОНІСТИ 5НТ<sub>4</sub> РЕЦЕПТОРА, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ | |
EP1194421A4 (fr) | Antagonistes selectifs du npy (y5) | |
SE9503924D0 (sv) | Novel opioid peptides | |
TR200100241T2 (tr) | Nosiseptin reseptörü ORL-1 için yüksek çekim gücü olan ligandlar | |
RU2000119773A (ru) | Пептиды-агонисты к-опиоидных рецепторов | |
EP1393722A3 (fr) | Utilisation d'antagonistes de l'angiotensine de type II (AT1) dans la fabrication d'un médicament pour le traitement du syndrome prémenstruel | |
HK1092135A1 (en) | (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo [3.2.0]heptane is an effective analgesic agent | |
EP0357030A3 (en) | Use of thromboxane a2 receptor antagonists for the preparation of a pharmaceutical composition for treating skin injuries | |
NZ337827A (en) | Use of GluR5 receptor antagonists in the manufacture of medicaments for treating pain | |
CA2378613A1 (fr) | Antagonistes selectifs du recepteur iglur5 utilises dans le traitement de la migraine | |
IL206566A0 (en) | Use of an antagonist to the igs4 neuromedin receptor polypeptide for the preparation of a medicament for the treatment of a disease related to the expression or acitivity of the igs4 neuromedin receptor polypeptide | |
WO2000048581A3 (fr) | Utilisation d'antagonistes du recepteur 5-ht¿3? | |
AP2002002501A0 (en) | Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog. | |
WO1998031704A3 (fr) | Antagonistes de tachykinine | |
JPH08502068A (ja) | イノシトール1,4,5‐トリスホスフェートを拮抗する方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AT AU BB BG BR CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) |
Free format text: AT,BB,BG,BR,CZ,DE,DK,FI,GB,HU,KP,KZ,LK,LU,MG,MN,MW,NL,NO,NZ,PL,PT,RO,RU,SD,SE,SK,UA, OAPI PATENT(BF,BJ,CF,CG,CI,CM,GA,GN,ML,MR,NE,SN,TD,TG) |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AT AU BB BG BR CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1993914854 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2139440 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 1995 360669 Country of ref document: US Date of ref document: 19950309 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1993914854 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993914854 Country of ref document: EP |